FHTX
Foghorn Therapeutics Inc
2.00$
+0.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 84.7% | 84.0% | 82.9% | 88.1% | 88.0% | 87.9% | 87.1% | 90.1% | 89.8% | 82.4% | 84.6% | 83.6% | |
| 22.4% | 28.1% | 31.1% | 42.3% | 18.7% | 19.5% | 23.6% | 32.1% | 43.6% | 40.8% | 40.0% | 33.5% | |
| 82.9% | 81.9% | 81.0% | 86.8% | 86.7% | 85.8% | 85.3% | 87.8% | 88.0% | 80.2% | 83.2% | 82.4% | |
| 118.3% | 127.0% | 138.2% | 104.4% | 109.2% | 116.0% | 123.8% | 133.9% | 143.7% | 154.8% | 134.4% | 139.8% | |
| 16.6% | 20.4% | 20.4% | 15.5% | 18.4% | 23.6% | 27.6% | 34.4% | 41.5% | 30.2% | 29.0% | 24.9% | |
| 2.7% | 3.0% | 3.4% | 2.5% | 2.8% | 3.2% | 3.5% | 2.7% | 3.3% | 0.5% | 0.8% | 1.4% | |
| 2.1% | 2.2% | 2.2% | 1.5% | 1.1% | 1.3% | 1.6% | 1.5% | 1.6% | 2.2% | 1.5% | 1.6% | |
| -18.3% | -27.0% | -38.2% | -4.4% | -9.2% | -16.0% | -23.8% | -33.9% | -43.7% | -54.8% | -34.4% | -39.8% | |
| -142.8% | -164.9% | -194.7% | -158.1% | -174.7% | -196.6% | -223.1% | -263.0% | -298.0% | -319.3% | -293.6% | -324.3% | |
| 13.4% | 14.8% | 16.6% | 15.7% | 20.3% | 22.0% | 24.3% | 27.8% | 30.8% | 31.8% | 31.3% | 34.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.